<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang CC</submitter><funding>Chang Gung University</funding><funding>Chang Gung Memorial Hospital</funding><pagination>100613</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10950825</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>47(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Diabetic kidney disease (DKD) is one of the most significant public health burdens worldwide. This study explored the renal protections of combined adipose-derived mesenchymal stem cells (ADMSCs) and empagliflozin (EMPA) in DKD rats.&lt;h4>Methods&lt;/h4>Adult-male-SD rats were equally allocated into group 1 (sham-operated-control), group 2 (DKD), group 3 (DKD + EMPA/20 mg/kg/day since day-14 after CKD-induction), group 4 [DKD + ADMSCs (6.0 × 10&lt;sup>5&lt;/sup>/intrarenal-arterial-injection/post-day-28, followed by 1.2 × 10&lt;sup>6&lt;/sup>/intravenous injection post-days 35 and 42 after CKD-induction, i.e., defined as repeated administration)] and group 5 (DKD + ADMSCs + EMPA) and kidney was harvested post-day-60 CKD-induction.&lt;h4>Results&lt;/h4>The result showed that the blood sugar and circulatory levels of BUN/creatinine and the ratio of urine protein/creatinine at day 60 were greatly increased in group 2 as compared the SC (i.e., group 1), significantly increased in groups 3 and 4 than in groups 5, but these parameters showed the similar manner in groups 3 and 4, except for blood sugar that was significantly lower in group 3 than in group 4 (all p &lt; 0.0001). The protein levels of inflammation (NF-κB/FNF-α/MMP-9)/oxidative-stress (NOX-1/NOX-2/oxidized protein/p22-phox)/apoptosis (cleaved-caspase-3/cleaved-PARP/mitochondrial-Bax)/fibrosis (TGF-β/Smad 3)/mitochondrial/DNA-damaged (p-DRP1/γ-H2AX) biomarkers revealed a similar manner of creatinine level among the groups (all p &lt; 0.0001). Kidney injury score/fibrotic area/oxidative-stress score (8-OHdG) and cellular levels of kidney-damaged biomarkers (KIM-1/γ-H2AX) showed a unanimous manner. In contrast, the cellular expressions of podocyte components (ZO-1/synaptopodin) revealed an antithetical manner of creatinine among the groups (all p &lt; 0.0001).&lt;h4>Conclusion&lt;/h4>Combined ADMSCs-EMPA was superior to just one therapy for protecting kidney function and ultra-structural integrity in DKD rodents.</pubmed_abstract><journal>Biomedical journal</journal><pubmed_title>Repeated administration of adipose-derived mesenchymal stem cells added on beneficial effects of empagliflozin on protecting renal function in diabetic kidney disease rat.</pubmed_title><pmcid>PMC10950825</pmcid><funding_grant_id>CMRPG8L0211</funding_grant_id><pubmed_authors>Yang CC</pubmed_authors><pubmed_authors>Li YC</pubmed_authors><pubmed_authors>Sung PH</pubmed_authors><pubmed_authors>Yip HK</pubmed_authors><pubmed_authors>Chiang JY</pubmed_authors><pubmed_authors>Chen CH</pubmed_authors><pubmed_authors>Chen YL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Repeated administration of adipose-derived mesenchymal stem cells added on beneficial effects of empagliflozin on protecting renal function in diabetic kidney disease rat.</name><description>&lt;h4>Background&lt;/h4>Diabetic kidney disease (DKD) is one of the most significant public health burdens worldwide. This study explored the renal protections of combined adipose-derived mesenchymal stem cells (ADMSCs) and empagliflozin (EMPA) in DKD rats.&lt;h4>Methods&lt;/h4>Adult-male-SD rats were equally allocated into group 1 (sham-operated-control), group 2 (DKD), group 3 (DKD + EMPA/20 mg/kg/day since day-14 after CKD-induction), group 4 [DKD + ADMSCs (6.0 × 10&lt;sup>5&lt;/sup>/intrarenal-arterial-injection/post-day-28, followed by 1.2 × 10&lt;sup>6&lt;/sup>/intravenous injection post-days 35 and 42 after CKD-induction, i.e., defined as repeated administration)] and group 5 (DKD + ADMSCs + EMPA) and kidney was harvested post-day-60 CKD-induction.&lt;h4>Results&lt;/h4>The result showed that the blood sugar and circulatory levels of BUN/creatinine and the ratio of urine protein/creatinine at day 60 were greatly increased in group 2 as compared the SC (i.e., group 1), significantly increased in groups 3 and 4 than in groups 5, but these parameters showed the similar manner in groups 3 and 4, except for blood sugar that was significantly lower in group 3 than in group 4 (all p &lt; 0.0001). The protein levels of inflammation (NF-κB/FNF-α/MMP-9)/oxidative-stress (NOX-1/NOX-2/oxidized protein/p22-phox)/apoptosis (cleaved-caspase-3/cleaved-PARP/mitochondrial-Bax)/fibrosis (TGF-β/Smad 3)/mitochondrial/DNA-damaged (p-DRP1/γ-H2AX) biomarkers revealed a similar manner of creatinine level among the groups (all p &lt; 0.0001). Kidney injury score/fibrotic area/oxidative-stress score (8-OHdG) and cellular levels of kidney-damaged biomarkers (KIM-1/γ-H2AX) showed a unanimous manner. In contrast, the cellular expressions of podocyte components (ZO-1/synaptopodin) revealed an antithetical manner of creatinine among the groups (all p &lt; 0.0001).&lt;h4>Conclusion&lt;/h4>Combined ADMSCs-EMPA was superior to just one therapy for protecting kidney function and ultra-structural integrity in DKD rodents.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2025-04-22T08:23:27.974Z</modification><creation>2025-04-05T22:32:12.817Z</creation></dates><accession>S-EPMC10950825</accession><cross_references><pubmed>37355087</pubmed><doi>10.1016/j.bj.2023.100613</doi></cross_references></HashMap>